Amaya Fadke calls out pharma's dangerous tendency to oversimplify tech development and overcomplicate evidence generation for digital therapeutics.
As heard by us
A practical look at how pharma and health tech partners build trust, share responsibility, and learn by doing.
This episode presents pharma and health tech partnerships as something closer to a working relationship than a simple vendor deal. Its clearest point is that both sides need intellectual honesty about what pharma can do well, what should be handled by partners, and why the work…
Why you'd press play
You want a sober map for pharma-healthtech partnerships built on trust and scale.
Listen to the show on